The activities of 5β-reductase and 11β-hydroxysteroid dehydrogenase in essential hypertension
- 30 November 1994
- Vol. 59 (11) , 656-660
- https://doi.org/10.1016/0039-128x(94)90022-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- 11β‐HYDROXYSTEROID DEHYDROGENASE ACTIVITY IN MESENTERIC ARTERIES OF SPONTANEOUSLY HYPERTENSIVE RATSClinical and Experimental Pharmacology and Physiology, 1993
- Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoformEndocrinology, 1993
- Detection of glycyrrhetinic acid-like factors (GALFs) in human urine.Hypertension, 1992
- 11β‐Hydroxysteroid dehydrogenase and enzyme‐mediated receptor protection: Life after liquorice?Clinical Endocrinology, 1991
- Potentiation of hydrocortisone activity in skin by glycyrrhetinic acidThe Lancet, 1990
- The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3α- and 3β-hydroxysteroid dehydrogenases and 5α- and 5β-reductase pathways of metabolism of aldosterone in male ratsSteroids, 1990
- 11β-Hydroxysteroid dehydrogenase and the meaning of lifeMolecular and Cellular Endocrinology, 1990
- A new form of the syndrome of apparent mineralocorticoid excessJournal of Steroid Biochemistry, 1989
- Dexamethasone Suppression in Essential Hypertension: Effects on Cortisol and Blood PressureClinical and Experimental Hypertension. Part A: Theory and Practice, 1989
- CONGENITAL 11β‐HYDROXYSTEROID DEHYDROGENASE DEFICIENCY ASSOCIATED WITH JUVENILE HYPERTENSION: CORTICOSTEROID METABOLITE PROFILES OF FOUR PATIENTS AND THEIR FAMILIESClinical Endocrinology, 1985